Front. Toxicol. Frontiers in Toxicology Front. Toxicol. 2673-3080 Frontiers Media S.A. 1394396 10.3389/ftox.2024.1394396 Toxicology Correction Corrigendum: Development of new approach methods for the identification and characterization of endocrine metabolic disruptors—a PARC project Braeuning et al. 10.3389/ftox.2024.1394396 Braeuning Albert 1 * Balaguer Patrick 2 Bourguet William 3 Carreras-Puigvert Jordi 4 Feiertag Katreece 5 Kamstra Jorke H. 6 Knapen Dries 7 Lichtenstein Dajana 1 Marx-Stoelting Philip 5 Rietdijk Jonne 4 Schubert Kristin 8 Spjuth Ola 4 Stinckens Evelyn 7 Thedieck Kathrin 9 van den Boom Rik 7 Vergauwen Lucia 7 von Bergen Martin 8 Wewer Neele 1 Zalko Daniel 10 1 Department of Food Safety, German Federal Institute for Risk Assessment, Berlin, Germany 2 IRCM (Institut de Recherche en Cancérologie de Montpellier), Inserm U1194, Université de Montpellier, ICM, Montpellier, France 3 CBS Centre de Biologie Structurale, Université de Montpellier, CNRS, Inserm, Montpellier, France 4 Department of Pharmaceutical Biosciences and Science for Life Laboratory, Uppsala University, Uppsala, Sweden 5 Department of Pesticides Safety, German Federal Institute for Risk Assessment, Berlin, Germany 6 Department of Population Health Sciences, Institute for Risk Assessment Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands 7 Zebrafishlab, Veterinary Physiology and Biochemistry, Department of Veterinary Sciences, University of Antwerp, Wilrijk, Belgium 8 Department of Molecular Systems Biology, Helmholtz Centre for Environmental Research (UFZ), Leipzig, Germany 9 Institute of Biochemistry and Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck, Austria 10 Toxalim (Research Centre in Food Toxicology), Université de Toulouse, Institut National de Recherche Pour L’Agriculture, L’Alimentation et L’Environnement (INARE), Ecole Nationale Vétérinaire de Toulouse (ENVT), INP-Purpan, Université Paul Sabatier (UPS), Toulouse, France

Edited and reviewed by: Bengt Fadeel, Karolinska Institutet (KI), Sweden

 *Correspondence: Albert Braeuning, albert.braeuning@bfr.bund.de 25 03 2024 2024 6 1394396 01 03 2024 15 03 2024 Copyright © 2024 Braeuning, Balaguer, Bourguet, Carreras-Puigvert, Feiertag, Kamstra, Knapen, Lichtenstein, Marx-Stoelting, Rietdijk, Schubert, Spjuth, Stinckens, Thedieck, van den Boom, Vergauwen, von Bergen, Wewer and Zalko. 2024 Braeuning, Balaguer, Bourguet, Carreras-Puigvert, Feiertag, Kamstra, Knapen, Lichtenstein, Marx-Stoelting, Rietdijk, Schubert, Spjuth, Stinckens, Thedieck, van den Boom, Vergauwen, von Bergen, Wewer and Zalko

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Corrigendum on Development of new approach methods for the identification and characterization of endocrine metabolic disruptors—a PARC project by Braeuning A, Balaguer P, Bourguet W, Carreras-Puigvert J, Feiertag K, Kamstra JH, Knapen D, Lichtenstein D, Marx-Stoelting P, Rietdijk J, Schubert K, Spjuth O, Stinckens E, Thedieck K, van den Boom R, Vergauwen L, von Bergen M, Wewer N and Zalko D (2023). Front. Toxicol. 5:1212509. doi: 10.3389/ftox.2023.1212509 endocrine metabolic disruption energy metabolism obesogens nuclear receptors adipocytes liver section-at-acceptance In Vitro Toxicology

In the published article, there was an error. In Section 5 an erroneous entry was introduced, indicating an opposite effect of what was shown in the reference referring to that entry.

A correction has been made to ‘5 Measures for obesogenic effects of MDCs’, paragraph 2. This sentence previously started:

“In contrast, in human bone marrow-derived mesenchymal stem cells (hMSCs), BPA alternatives attenuated adipogenesis (Norgren et al., 2022), stressing the importance to research mechanisms and variable exposure scenarios.”

The corrected sentence appears below:

“In contrast, in human bone marrow-derived mesenchymal stem cells (hMSCs), BPA alternatives induced adipogenesis (Norgren et al., 2022), stressing the importance to research mechanisms and variable exposure scenarios.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.